Navigation Links
Statement from the Consumer Healthcare Products Association (CHPA) on Annual Monitoring the Future Survey on Drug Abuse
Date:12/14/2011

WASHINGTON, Dec. 14, 2011 /PRNewswire-USNewswire/ -- Consumer Healthcare Products Association (CHPA) President and CEO Scott Melville issued the following statement regarding today's release of the 2011 National Institute on Drug Abuse's (NIDA's) Monitoring the Future survey, which found that cough medicine abuse among twelfth graders has decreased by 1.2 percent in the last year. Abuse among eighth and tenth graders remained stable, at 2.7 and 5.5 percent respectively. 

"The results of this year's National Institute on Drug Abuse's (NIDA's) Monitoring the Future survey show that abuse of cough medicine has leveled off and even decreased among twelfth graders. However, teens turning to the medicine cabinet to get high remains a persistent and concerning behavior, and the leading makers of over-the-counter medicines will continue our many efforts to stop this behavior.

"Research shows that kids whose parents talk to them about the about the risks of drugs are 50 percent less likely to use. Partnering with drug abuse prevention experts, we have raised awareness among millions of families in communities across the country about the dangers of over-the-counter cough medicine abuse. Through retail initiatives, community events, and media, we will continue to provide information, guidance and support to give parents the tools they need to prevent their teens from abusing cough medicine.

"As we work to empower parents to talk to their teens and to monitor the medicines in their homes, we also are also pushing the federal government to give parents additional support. We continue to call upon Congress to pass a federal bill that would ban individuals under the age of 18 from purchasing cough medicine containing dextromethorphan (DXM). DXM is the most widely used cough suppressant and has been relied upon by American families for more than 50 years, but we recognize some report abusing large quantities. We believe parents should be in control of the medicines that enter their homes, and that teens should not be buying these medicines."

For more information on CHPA's campaign to stop cough medicine abuse, go to StopMedicineAbuse.org.

CHPA is the 130-year-old-trade association representing U.S. manufacturers and distributors of over-the-counter medicines and dietary supplements.

chpa-info.org


 


'/>"/>
SOURCE Consumer Healthcare Products Association
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Nationwide Coalition Responds to Express Scripts CEO Statement: "I Cant Stop Certain Pharmacies From Going Out of Business"
2. Statement from FDA Commissioner Margaret Hamburg, M.D. on Plan B One-Step
3. Abbott Statement on the Results of the AIM-HIGH Study Presented at AHA 2011
4. Amgen Statement on European Investor Visit
5. FDA Statement on Makena
6. Cempra Holdings, LLC Files Registration Statement for Proposed Initial Public Offering
7. Alere Inc. Statement Regarding Recommended Increased Cash Offer to Acquire Axis-Shield
8. Alere Inc. Statement Regarding Axis-Shield Offer
9. Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer
10. Visual Healthcare Corp. Files Year-End Disclosure Statement
11. Statement from the Michigan Society of Anesthesiologists in Response to Governor Snyders Health & Wellness Announcement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... , Dec. 5, 2016   Lexicon Pharmaceuticals, ... results today from a Phase 2 clinical study of ... Lexicon in collaboration with JDRF, the leading global organization ... of this Phase 2 clinical trial, which randomized a ... of a once-daily 400 mg dose of sotagliflozin compared ...
(Date:12/5/2016)... , December 5, 2016 According to ... Treatment modalities (Chondrocyte Transplantation, Growth Factor Technology, Tissue Scaffolds, Cell-free composites), ... by MarketsandMarkets, the market is projected to reach USD 779.8 Million ... CAGR of 13.5% during the forecast period of 2016 to 2021. ... ...
(Date:12/5/2016)... PORTLAND, Oregon and PUNE, India ... a new report by Allied Market Research, titled, "Global Cancer ... the global revenue of cancer biomarkers market is projected to ... at a CAGR of 13.3% from 2016 to 2022. Omic ... share in 2015 and is expected to maintain its dominance ...
Breaking Medicine Technology:
(Date:12/6/2016)... , ... December 06, 2016 ... ... on Friday, November 25th, when SevenPoint2 released the much-anticipated HydroFX for Water®. ... eye-catching label design. Featuring one of the world’s most powerful antioxidants, molecular ...
(Date:12/6/2016)... ... December 06, 2016 , ... TopConsumerReviews.com recently gave a ... Scooters . , Mobility Scooters give freedom to people who need help getting around. ... may be facing a long period of rehabilitation after an illness or accident. There ...
(Date:12/5/2016)... ... December 05, 2016 , ... "FCPX Overlay Glare is a ... lighting effect without heavy rendering or complicated compositing," said Christina Austin - CEO of ... create an organic spectrum of lights that simulates the look of a glare. ...
(Date:12/5/2016)... GA (PRWEB) , ... December ... ... technology and security executive networking and relationship-marketing firm, announced today that nominations ... the 2017 Information Security Executive® (ISE®) Central Awards. , Awards include the ...
(Date:12/5/2016)... ... December 05, 2016 , ... Physicians Education ... Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma, on ... “We are honored to have Amy E. Herman present at this year’s conference, ...
Breaking Medicine News(10 mins):